Skip to main content

Learning at Dana-Farber Online Courses

  • Just Culture: A Key to Quality and Safety


    Course Experts: Andrew Stivers, PharmD

    Course Description: This course identifies and defines medication system failures as well as compares and contrasts human error, at risk behavior, and reckless behavior. It explains how to apply just culture principles in your practice.

    Credits: CEUs will be granted for pharmacists and pharmacy technicians in patient safety.
    Just Culture, Patient Safety, Active Failure, Latent Condition, Systems Approach, Human Error,...
  • ITP An Update: New Routes, New Options and New Outcomes


    Course Experts: Shahrier Hossain, PharmD

    Course Description: This course compares different treatment options for chronic thrombocytopenia, recommends a thrombopoietin agonist based on patient-specific factors, and identifies the role of fostamatinib in therapy.

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.
    Immune Thrombocytopenia (ITP), Thrombocytopenia, Fostamatinib, Splenectomy, Rituximab, TPO Receptor Agonists...
  • Human Factors in the Ambulatory Oncology Setting


    Course Experts: Emily Messing, PharmD, BCPS

    Course Description: This course reviews human factorsand how human factors engineering can be used to improve patient safety in the oncology settings.

    Credits: CEUS will be granted to pharmacists and pharmacy technicians in patient safety.
  • Fast Food or Fine Dining: Reviewing Bispecific Antibodies and Chimeric Antigen Receptor T-cells


    Course Experts: Shahrier Hossain, PharmD, BCOP; Ashka Patel, PharmD, BCOP; Charles Ni, PharmD, MPH, BCOP; Emily Tiao, PharmD, BCOP

    Course Description: This course covers the workings of CAR-T therapy and bispecific antibodies, assessing major trials, efficacy, safety, and managing side effects like cytokine release syndrome and neurotoxicity associated with these treatments.

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.
  • Exploring the Evolving Field of Chronic Graft-Versus-Host Disease: Management Strategies


    Course Experts: Melinda Cook, PharmD and Eno Inyang, PharmD, BCPS, BCOP

    Course Description: This course examines chronic GVHD pathophysiology, novel treatment options, evaluates prophylactic therapies for prevention, and analyzes treatments for both steroid-naïve and steroid-refractory cases.

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.
    Chronic Graft-Versus-Host Disease (GVHD), Prophylactic Therapies, Steroid-Nai...
  • Emergency Responses in a Pediatric Ambulatory Oncology Clinic


    Course Experts: Patrick McBride, PharmD, BCOP

    Course Description: This course summarizes appropriate management for pediatric infusion reactions and pediatric seizures. It compares the differences between pediatric and adult code cart contents and dosing references.

    Credits: CEUs will be granted for pharmacists in patient safety.
    Pediatric Oncology, Infusion Reactions, Seizures, Status Epilepticus, Code Cart, Febrile Neutropenia, Sepsis, Septic Shock, Bros...
  • Drug Diversion, Detection and Prevention


    Course Experts: Iman Suliman, PharmD, BCACP

    Course Description: This course will review the fundamentals of drug diversion detection and prevention. Drug diversion is often underreported and can be difficult to detect in healthcare organizations; therefore, education is key.

    Credits: CEUs will be granted for pharmacists and pharmacy technicians in pharmacy administration.
    Drug Diversion, Healthcare, Opioids, Fentanyl, Overdose, Signs and Symptoms, Substan...
  • Colorectal Cancer: An Overview


    Course Experts: Nina Grenon, DNP, AOCN; Samantha Morrison-Ma, CNP, MSN, RN, ANP-C, WHNP-BC; and Leila Rostamnjad, PharmD, BCOP

    Course Description: This course provides an overview of colorectal cancer including colorectal cancer risk, diagnosis, pathology, treatment, and management of treatment-related adverse effects.

    Credits: CEUs will be granted for pharmacists in disease state management.
    Colorectal Cancer (CRC), Risk Factors, Staging, Pathophysiology...
  • Clinical Pearls for Methadone Use in Oncology and Palliative Care


    Course Experts: Annabelle Hood, PharmD; Molly Bacon, PharmD and Iman Suliman, PharmD, BCACP

    Course Description: This course identifies unique pharmacokinetic and pharmacodynamic properties of methadone in the palliative care setting and describes factors in determining cardiac monitoring of methadone.

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.
    Methadone, Pharmacokinetics, Pharmacodynamics, Palliative Care, Onco...
  • CINV: Ongoing Issues and Updated Solutions


    Course Experts: Iman Suliman, PharmD, BCACP and Kimberly Noonan, DNP, ANP-BC, AOCN

    Course Description: This course reviews the updates in classes of highly, moderate, and low emetogenic intravenous and oral anticancer agents and the appropriate corresponding management strategies for Chemotherapy Induced Nausea and Vomiting (CINV).

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.
    CINV (Chemotherapy-Induced Nausea and ...
  • Chemotherapy-Induced Peripheral Neuropathy: A Review of the Guidelines


    Course Experts: Molly Bacon, PharmD

    Course Description: This course will define CIPN, identify risk factors and causative agents and discuss the literature supporting non-pharmacologic and pharmacologic preventative and treatment methods.

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.
    Chemotherapy-Induced Peripheral Neuropathy (CIPN), Risk Factors, Causative Agents, Nonpharmacologic Treatments, Pharmacologic Treatme...
  • Cardiotoxicity in Breast Cancer


    Course Experts: Anju Nohria, MD, MSc; Amal Arnaout, PharmD; and Iman Suliman, PharmD, BCACP

    Course Description: This course explains the intersection between breast cancer and cardiovascular disease. It outlines cardiotoxicities of breast cancer therapy and identifies the available treatment options in the setting of cardiotoxicity.

    Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.